NCT02741193View on ClinicalTrials.gov

Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 10, 2016

Primary Completion Date

November 17, 2016

Study Completion Date

February 23, 2023

Conditions
Epilepsy
Interventions
DEVICE

The Magstim Rapid2,

"Transcranial Magnetic Stimulation, which is a microprocessor-controlled machine which delivers both single and repetitive transcranial magnetic stimulation (TMS).~single and repetitive transcranial magnetic stimulation (TMS). TMS will be applied as single pulses to determine motor evoked potentials (MEPs), there will be no modulation of cortical excitability."

Trial Locations (1)

10016

New York University Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02741193 - Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) | Biotech Hunter | Biotech Hunter